Document is current
Any future updates will be listed below
-
Authors
Chua, Andy J. https://orcid.org/0000-0003-4796-7764
Di Francesco, Valentina https://orcid.org/0000-0003-4216-724X
D’Souza, Anisha https://orcid.org/0000-0003-2457-671X
Amiji, Mansoor https://orcid.org/0000-0001-6170-881X
Bleier, Benjamin S.
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (MOH-RTF21nov-0008)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS108968-01)
- License Information
-
More Information
Article History
Received: 30 December 2022
Accepted: 14 October 2024
First Online: 15 November 2024
Competing interests
: A.J.C. received consulting fees from Acclarent Inc, MicrogenDx, and Elsevier Inc. B.S.B. holds a patent assigned to Massachusetts Eye and Ear covering transmucosal delivery methods to the CNS. All other authors declare no competing interests.
